Ecopetrol
EC
Apple
AAPL
D.R. Horton
DHI
4
Meritage Homes
MTH
5
Lennar Corp
LEN
US Stock MarketDetailed Quotes
CABA Cabaletta Bio
- 1.385
- -0.165-10.65%
Close Mar 31 16:00 ET
- 1.360
- -0.025-1.81%
Post 20:01 ET
67.69MMarket Cap-0.59P/E (TTM)
1.510High1.360Low1.62MVolume1.480Open1.550Pre Close2.29MTurnover3.91%Turnover RatioLossP/E (Static)48.88MShares19.04052wk High0.44P/B57.57MFloat Cap1.36052wk Low--Dividend TTM41.57MShs Float26.350Historical High--Div YieldTTM9.68%Amplitude0.590Historical Low1.410Avg Price1Lot Size
About Cabaletta Bio Company
Cabaletta Bio, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in April 2017 and is headquartered in Philadelphia, PA.
Company Profile
SymbolCABA
Company NameCabaletta Bio
Listing DateOct 25, 2019
Issue Price11.00
Founded2017
CEODr. Steven Nichtberger,M.D.
MarketNASDAQ
Employees103
Fiscal Year Ends12-31
Address2929 Arch Street,Suite 600
CityPhiladelphia
ProvincePennsylvania
CountryUnited States of America
Zip Code19104
Phone1-267-759-3100
Websitehttp://www.cabalettabio.com
Company Executives
- Name
- Position
- Salary
- Dr. Steven Nichtberger,M.D.
- Chairman of the Board, President and Chief Executive Officer
- 4.81M
- David J. Chang, M.D.,M.P.H.
- Chief Medical Officer
- 2.10M
- Arun Das, M.D.
- Chief Business Officer
- --
- Anup Marda, M.B.A.
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Gwendolyn K. Binder-Scholl, M.D.,PhD
- President, Science and Technology
- 2.34M
- Shawn Cline Tomasello, M.B.A.
- Independent Director
- 509.94K
- Catherine Bollard, M.D.
- Independent Director
- 255.43K
- Richard C. Henriques, M.B.A.
- Independent Director
- 259.20K
- Mark Simon, M.B.A.
- Independent Director
- 260.15K
- Dr. Scott C. Brun, M.D.
- Independent Director
- 255.83K
- Michael Gerard, J.D.
- General Counsel and Secretary
- --
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings